BIGG

Resultados: 3

Directrices unificadas de la OMS sobre el tratamiento de la tuberculosis farmacorresistente

Las cepas del bacilo tuberculoso con farmacorresistencia (TB-DR) son más difíciles de tratar que las farmacosensibles y amenazan el progreso mundial hacia los objetivos establecidos por la Estrategia Fin de la TB, de la Organización Mundial de la Salud (OMS). Por lo tanto, existe una necesidad imperio...

WHO treatment guidelines for isoniazid-resistant tuberculosis: Supplement to the WHO treatment guidelines for drug-resistant tuberculosis

Isoniazid (H) is one of the most important first-line medicines for the treatment of active tuberculosis (TB) and latent TB infection (LTBI), with high bactericidal activity and a good safety profile. The emergence of TB strains resistant to isoniazid threaten to reduce the effectiveness of TB treatment....

The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin

Tuberculosis (TB) remains a large-scale public health problem. Key global priorities for TB care and control include improving case-detection and detecting cases earlier, including cases of smear-negative disease. This document updates existing WHO policy on the use of molecular LPAs for detecting MTBC a...